On today’s special guest episode, we’ll be exploring the topic of nitrous oxide with Dr. Charles Conway and Dr. Vasilis Hristidis.

https://medicine.washu.edu/news/laughing-gas-relieves-symptoms-in-people-with-treatment-resistant-depression/

https://pmc.ncbi.nlm.nih.gov/articles/PMC5825282/

https://pubmed.ncbi.nlm.nih.gov/34108247/

https://pubmed.ncbi.nlm.nih.gov/25577164/

In today’s episode, we explore ketamine’s therapeutic potential with Dr. Joshua Rosenblat, a leading expert and faculty member at the University of Toronto’s Department of Psychiatry (learn more).

https://x.com/jd_rosenblat?lang=en

https://pubmed.ncbi.nlm.nih.gov/35688035/

https://pubmed.ncbi.nlm.nih.gov/39608193/

Welcome back! Today, we are discussing a new branded medication that combines bupropion with dextromethorphan for the treatment of depression.

Today, we will be discussing tricyclic antidepressants (TCA's). Once again, we've picked a few of our favorites to discuss on today's episode.

Welcome back! Today, we will be discussing MAOIs, and we've picked out a few of our favorites for today's episode.

Could there be an evolutionary perspective for depression? Join us for part two of our series on depression and inflammation.

Join us as we talk about the relationship between depression and inflammation - an interesting biological theory.

Join us as we talk about Loxapine, an older medication that’s stood the test of time and found a niche in psychiatric practice.

Welcome back! Today, we have a special guest-episode with a senior medical student, Jun-Hwan Kim. Join us as we talk about anti-psychotic associated weight gain.

Today, we have a very special guest joining us—Dr. John Kane! We will be discussing his experience and history with clozapine, a groundbreaking medication for treatment-resistant schizophrenia.